Snake venom metalloproteinases and disintegrins: Interactions with cells

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 7, 1998, Pages 853-862

  Kamiguti, A S ^a   Zuzel, M ^a   Theakston, R D G ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Disintegrin; Integrin; Metalloproteinase; Platelet; Signaling; Venom

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CELL SURFACE RECEPTOR; CYSTEINE; DISINTEGRIN; INTEGRIN; METALLOPROTEINASE; SNAKE VENOM; VIPER VENOM;

AMINO TERMINAL SEQUENCE; BLEEDING; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CELL SURFACE; ENZYME MECHANISM; HEMOSTASIS; HUMAN; MAMMAL; NONHUMAN; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

MAMMALIA; SERPENTES; VIPER; VIPERIDAE;

EID: 0031847147     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000700001     Document Type: Review

References (86)

1. Seegers WH & Ouyang C (1979). Snake venoms and blood coagulation. Handbook of Experimental Pharmacology, 52: 684-750.
2. Ouyang C, Teng C-M & Huang T-F (1992). Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon, 30: 945-966.
3. Hutton RA & Warrell DA (1993). Action of snake venom components on the haemostatic system. Blood Reviews, 7: 176-189.
4. Kamiguti AS & Sano-Martins IS (1995). South American snake venoms affecting haemostasis. Journal of Toxicology, Toxin Reviews, 14: 359-374.
5. Bjarnason JB & Fox JW (1994). Hemorrhagic metalloproteinases from snake venoms. Pharmacology and Therapeutics, 62: 325-372.
6. Bjarnason JB & Fox JW (1988/89). Hemorrhagic toxins from snake venoms. Journal of Toxicology, Toxin Reviews, 7: 121-209.
7. Bithell TC (1993). The physiology of primary haemostasis. In: Lee JR, Bithell TC, Foester J, Athens JW & Lukens JN (Editors), Wintrobe's Clinical Hematology. Lea & Febiger, London.
8. Hynes RO (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69: 11-25.
9. Baumgartner HR, Tschoop TB & Weiss HJ (1978). Defective adhesion of platelets to subendothelium in von Willebrand's disease and Bernard Soulier syndrome. Thrombosis and Haemostasis, 39: 782-783.
10. Weiss HJ, Turitto VT & Baumgartner HR (1986). Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa and Ib and storage α-granules. Blood, 67: 322-330.
11. Santoro SA, Rajpara SM, Staatz WD & Woods VL (1988). Isolation and characterization of a platelet surface collagen binding complex to VLA-2. Biochemical and Biophysical Research Communications, 153: 217-223.
12. Warrell DA, Ormerod LD & Davidson NMcD (1975). Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom. British Medical Journal, 20: 697-700.
13. Warrell DA, Davidson NMcD, Greenwood BM, Ormerod LD & Prentice CRM (1977). Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Quarterly Journal of Medicine, 46: 33-62.
14. Kouyoumdjian JA, Polizelli C, Lobo SMA & Guimarães SM (1991). Fatal extradural haematoma after snake bite (Bothrops moojeni). Transactions of the Royal Society of Tropical Medicine and Hygiene, 85: 552.
15. Gitter S & de Vries A (1968). Symptomatology, pathology and treatment of bites by Near Eastern, European and North African snakes. In: Bucherl W, Buckley EE & Deulofeu V (Editors), Venomous Animals and their Venoms. Academic Press, New York.
16. Kamiguti AS, Rugman FP, Theakston RDG, Franca FOS, Ishii H, Hay CRM & Butantan Institute Antivenom Study Group (1992). The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Thrombosis and Haemostasis, 67: 484-488.
17. Sliva MV & Buononato MA (1983/84). Relato clinico de envenenamento humano por Philodryas olfersii. Memórias do Institute Butantan, 47/48: 121-126.
18. Assakura MT, Salomāo MG, Puorto G & Mandelbaum FR (1992) Hemorrhagic, fibrinogenolytic and edema-forming activities of the venom of the colubrid Philodryas olfersii (green snake). Toxicon, 30: 427-437.
19. Theakston RDG & Reid HA (1983). The development of simple standard assay procedures for the characterization of snake venoms. Bulletin of the World Health Organization, 61: 949-956.
20. Kamiguti AS, Theakston RDG, Desmond HP & Hutton RA (1991). Systemic haemorrhage in rats induced by a haemorrhagic fraction from Bothrops jararaca venom. Toxicon, 29: 1097-1105.
21. Kornalik F (1992). Analysis of haemorrhagic diathesis (HD) and DIC due to snake venom enzymes on an experimental model. In: Gopalakrishnakone P & Tan CK (Editors), Recent Advances in Venom Research. National University of Singapore, Singapore.
22. Ohsaka A (1979). Hemorrhagic, necrotizing and edema-forming effects of snake venoms. Handbook of Experimental Pharmacology, 52: 480-546.
23. Ownby CL (1990). Locally acting agents: myotoxins, hemorrhagic toxins and dermonecrotic factors. In: Shier WT & Mebs D (Editors), Handbook of Toxicology. Marcel Dekker, New York.
24. Ohsaka A, Just M & Habermann E (1973). Action of snake venom principles on isolated glomerular basement membrane. Biochimica et Biophysica Acta, 323: 415-428.
25. Bjarnason JB & Tu AT (1978). Hemorrhagic toxins from Western diamondback rattlesnake (Crofalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e. Biochemistry, 17: 3395-3404.
26. Bjarnason JB, Hamilton D & Fox JW (1988). Studies on the mechanism of hemorrhage production by five proteolytic toxins from Crotalus atrox venom. Biological Chemistry Hoppe-Seyler, 369: 121-129.
27. Baramova EN, Shannon JD, Bjarnason JB & Fox JW (1989). Degradation of extracellular matrix proteins by haemorrhagic metalloproteinases. Archives of Biochemistry and Biophysics, 275: 63-71.
28. 2-macroglobulin. Biochemistry, 29: 1069-1074.
29. Lomonte B (1994). Tissue damage and inflammation induced by snake venoms. PhD thesis, Goteberg University.
30. Rosenfeld G (1971). Symptomatology, pathology and treatment of snake bites in South America. In: Bucherl W, Buckley E & Deulofeu V (Editors), Venomous Animals and their Venoms. Academic Press, New York.
31. Maruyama M, Kamiguti AS, Cardoso JLC, Sano-Martins IS, Chudzinski AM, Santoro ML, Morena P, Antonio LC, Mihara M & Kelen EMA (1990). Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (Jararaca). Thrombosis and Haemostasis, 63: 449-453.
32. Cardoso JLC, Fan HW, França FOS, Jorge MT, Leite RP, Nishioka SA, Avila A, Sano-Martins IS, Santoro ML, Chudzinski AM, Castro SCB, Kamiguti AS, Kelen EMA, Hirata MH, Mirandola RMS, Theakston RDG & Warrell DA (1993). Randomized comparative trial of three antivenoms in the treatment of envenoming by lanceheaded vipers (Bothrops jararaca) in São Paulo, Brazil. Quarterly Journal of Medicine, 86: 315-325.
33. Paine M, Desmond HP, Theakston RDG & Crampton JM (1992). Purification, cloning and molecular characterization of a high molecular weight hemorrhagic metalloproteinase, jararhagin, from Bothrops jararaca venom. Journal of Biological Chemistry, 267: 22869-22876.
34. 2-macroglobulin. Biochimica et Biophysica Acta, 1200: 307-314.
35. Pandya BV & Budzynski AZ (1984). Anticoagulant proteases from Western diamondback rattlesnake (Crotalus atrox) venom. Biochemistry, 23: 460-467.
36. Ouyang C, Teng C-M & Chen YC (1979). Properties of fibrinogen degradation products produced by α-and ß-fibrinogenases of Trimeresurus mucrosquamatus snake venom. Toxicon, 17: 121-126.
37. Markland FS (1991). Inventory of α-and ß-fibrinogenase from snake venoms. Thrombosis and Haemostasis, 65: 438-443.
38. Hawiger J, Timmons S, Kloczewiak M, Strong DD & Doolittle RF (1982). γand α chains of human fibrinogen possess sites reactive with human platelet receptors. Proceedings of the National Academy of Sciences, USA, 79: 2068-2071.
39. Plow EF, Srouji AH, Meyer D, Marguerie G & Ginsberg MH (1984). Evidence that three adhesive proteins interact with a common recognition site on activated platelets. Journal of Biological Chemistry, 259: 5388-5391.
40. Teng C-M & Huang T-F (1991). Inventory of exogenous inhibitors of platelet aggregation. Thrombosis and Haemostasis, 65: 624-626.
41. Kamiguti AS, Slupsky JR, Zuzel M & Hay CRM (1994). Properties of fibrinogen cleaved by jararhagin, a metalloproteinase from the venom of Bothrops jararaca. Thrombosis and Haemostasis, 72: 244-249.
42. 1 integrin by the snake venom metalloproteinase jararhagin. Biochemical Journal, 320: 635-641.
43. Kamiguti AS, Moura-da-Silva AM, Laing GD, Knapp T, Zuzel M, Crampton JM & Theakston RDG (1997). Collagen-induced secretion-dependent phase of platelet aggregation is inhibited by the snake venom metalloproteinase jararhagin. Biochimica et Biophysica Acta, 1335: 209-217.
44. Kamiguti AS, Hay CRM, Theakston RDG & Zuzel M (1995). Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon, 34: 627-642.
45. Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE & Fujiwara K (1986). Amino acid sequence of human von Willebrand factor. Biochemistry, 25: 3171-3184.
46. 3 integrins in hemostasis and vascular biology. Thrombosis and Haemostasis, 74: 149-155.
47. 1. Biochemical and Biophysical Research Communications, 206: 570-576.
48. 2+ mobilization in platelets. Journal of Biological Chemistry, 268: 2277-2279.
49. syk in collagen-induced signal transduction in platelets. European Journal of Biochemistry, 226: 243-248.
50. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K & Uchino H (1987). A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood, 69: 1712-1720.
51. Ichinobe T, Takayama H, Ezumi Y, Yanagi S, Yamamura H & Okuma M (1995). Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinase through platelet membrane glycoprotein VI. Journal of Biological Chemistry, 270: 28029-28036.
52. Nieuwenhuis HK, Akkerman JWM, Houdijk WPM & Sixma JJ (1985). Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature, 318: 470-472.
53. syk activation in human platelets stimulated with collagen is dependent upon glycoprotein Ia/IIa and actin polymerization. Thrombosis and Haemostasis, 75: 648-654.
54. syk. Journal of Biological Chemistry, 272: 32599-32605.
55. Santoro SA (1986). Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen. Cell, 46: 913-920.
56. ++-dependent adhesion of platelets to collagen. Journal of Cell Biology, 108: 1917-1924.
57. Huang T-F, Holt JC, Lukasiewcz H & Niewiarowski S (1987). Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb/IIIa complex. Journal of Biological Chemistry, 262: 16157-16163.
58. Niewiarowski S, MacLane MA, Klocsewiak M & Stewart GJ (1994). Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptor. Seminars in Hematology, 31: 289-300.
59. 3 subunit. Experimental Cell Research, 225: 132-142.
60. Usami Y, Fujimura Y, Miura S, Shima H, Yoshida E, Yoshioka A, Hirano K, Suzuki M &Titani K (1994). A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochemical and Biophysical Research Communications, 201: 331-339.
61. Clark EA, Trikha M, Markland FS & Brugge JS (1994). Structurally distinct disintegrins contortrostatin and multisquamatin differentially regulate platelet tyrosine phosphorylation. Journal of Biological Chemistry, 269: 21940-21943.
62. 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental matastasis. Cancer Research, 54: 4993-4998.
63. Knudsen KA, Tuszynski GP, Huang T-F & Niewiarowski S (1988). Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells. Experimental Cell Research, 179: 42-49.
64. Sheu JR, Lin CH & Huang T-F (1994). Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix through an arginine-glycine-aspartic acid-dependent mechanism. Journal of Laboratory and Clinical Medicine, 123: 256-263.
65. Beviglia L, Stewart GJ & Niewiarowski S (1995). Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncology Research, 7: 7-20.
66. Morris VL, Schmidt EE, Koop S, MacDonald IC, Grattan M, Khokha MA, MacLane MA, Niewiarowski S, Chambers AF & Groom AC (1995). Effects of the disintegrin eritostatin on individual steps of hematogenous metastasis. Experimental Cell Research, 219: 571-578.
67. Bronson RA, Gailit J, Bronson S & Oula L (1995). Echistatin, a disintegrin, inhibits sperm-oolemmal adhesion but not oocyte penetration. Fertility and Sterility, 64: 414-420.
68. Takeya H, Oda K, Miyata T, Omori-Satoh T & Iwanaga S (1990). The complete amino acid sequence of high molecular mass hemorrhagic protein HR1B isolated from the venom of Trimeresurus flavoviridis Journal of Biological Chemistry, 265: 16068-16073.
69. Hite LA, Shannon JD, Bjarnason JB & Fox JW (1992). Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox. evidence for signal, zymogen, and disintegrin-like structures. Biochemistry, 31: 6203-6211.
70. Kini R & Evans HJ (1992). Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon, 30: 265-293.
71. Moura-da-Silva AM, Theakston RDG & Crampton JM (1996). Evolution of disintegrin cysteine-rich and mammalian matrix-degrading metalloproteinases: gene duplication and divergence of a common ancestor rather than convergent evolution. Journal of Molecular Evolution, 43: 263-269.
72. Scarborough RM, Rose JW, Naughton MA, Phillips DR, Nannizzi L, Arfsten A, Campbell AM & Charo IF (1993). Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. Journal of Biological Chemistry, 268: 1058-1065.
73. Paine MJI, Moura-da-Silva AM, Theakston RDG & Crampton JM (1994). Cloning of metalloprotease genes in the carpet viper (Echis pyramidum leakeyi). Further members of the metalloprotease/disintegrin gene family. European Journal of Biochemistry, 224: 483-488.
74. Nishida S, Fujita T, Atoda H, Morita T, Takeya H, Kido I, Paine MJI, Kawabata S & Iwanaga S (1995). cDNA cloning and deduced amino acid sequence of prothrombin activator (Ecarin) from Kenyan Echis carinatus venom. Biochemistry, 34: 1771-1778.
75. Takeya H, Nishida S, Nishino N, Makinose Y, Omori-Satoh T, Nikai T, Sugihara H & Iwanaga S (1993). Primary structures of platelet aggregation inhibitors (disintegrins) autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorogenic peptide substrates for these enzymes. Journal of Biochemistry, 113: 473-483.
76. Wolfsberg TG, Primakoff P, Myles DG & White JM (1995). ADAM, a novel family of membrane containing A Disintegrin And Metalloproteinase domain: multipotential functions in cell-cell and cell-matrix interactions. Journal of Cell Biology, 131: 275-278.
77. Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff CW & White JM (1992). A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature, 356: 248-252.
78. 1 functions as a sperm receptor. Cell, 81: 1095-1104.
79. Wolfsberg TG, Straight PD, Gerena RL, Huovila A-P, Primakoff P, Myles DG & White JM (1995). ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with A Disintegrin And Metalloproteinase do-main. Developmental Biology, 169: 378-383.
80. Chantry A, Gregson N & Glynn P (1989). A novel metalloproteinase associated with brain myelin membranes. Journal of Biological Chemistry, 264: 21603-21607.
81. Howard L, Lu X, Mitchell S, Griffiths S & Glynn P (1996). Molecular cloning of MADMAM: a catalytically active mammalian disintegrin-metalloproteinase expressed in various cell types. Biochemical Journal. 317: 45-50.
82. Yagami-Hirosama T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y & Fujisawa-Sehara A (1995). A metalloproteinase-disintegrin participating in myoblast fusion. Nature, 377: 652-656.
83. Weskamp G, Kratzschmar J, Reid M & Blobel CP (1996). MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. Journal of Cell Biology, 132: 717-726.
84. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ & Cerretti DP (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature, 385: 729-733.
85. Moss ML, Jin S-LC, Milla ME, Burkhart W, Cartner HL, Chen W-J, Clay WC, Didsbury JR, Hassier D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su J-L, Warner J, Willard D & Becherer JD (1997). Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature, 385: 733-736.
86. Moura-da-Silva AM, Laing GD, Paine MJI, Dennison JMTJ, Politi V, Crampton JM & Theakston RDG (1996). Processing of tumor-necrosis factor-α by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite. European Journal of Immunology, 26: 2000-2005.